Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels

Journal of Endocrinological Investigation

Volumn 22, Issue 9, 1999, Pages 681-687

  Mazza, E ^a   Maccario, M ^c   Ramunni, J ^c   Gauna, C ^c   Bertagna, A ^c   Barberis, A M ^c   Patroncini, S ^a   Messina, M ^a   Ghigo, Ezio ^b  

^a MARIA VITTORIA HOSPITAL   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c Ospedale Molinette ^*

Author keywords

Age; Body mass; DHEA S; Insulin

Indexed keywords

INSULIN; PRASTERONE SULFATE;

ADULT; AGE; AGED; ARTICLE; BLOOD LEVEL; BODY MASS; FEMALE; HUMAN; INSULIN RELEASE; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; POSTMENOPAUSE;

EID: 0032736578     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343629     Document Type: Article

References (40)

1. Beaulieu E.E. Dehydroepiandrosterone (DHEA): a fountain of youth? J. Clin. Endocrinol. Metab. 1996, 81: 3147.
2. Orentreich N., Brind J.L., Rizer R.L., Vogelman J.H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J. Clin. Endocrinol. Metab. 1984, 59: 551-555.
3. Morales A.J., Nolan J.J., Nelson J.C., Yen S.S.C. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrinol. Metab. 1994, 78: 1360-1367.
4. Ravaglia G., Forti P., Maioli F., Boschi F., Bernardi M., Pratelli L., Pizzoferrato A., Gasbarrini G. The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. Results from an Italian study on healthy free-living over-ninety-year-old. J. Clin. Endocrinol. Metab. 1996, 87: 1173-1178.
5. Maccario M., Mazza E., Ramunni J., Oleandri S.E., Savio P., Grottoli S., Rossetto R., Procopio M., Gauna C., Ghigo E. Relationships between dehydroepiandrosterone-sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese women. Clin. Endocrinol. (Oxf.) 1999, 50: 595-600.
6. Ebeling P., Koivisto V.A. Physiological importance of dehydroepiandrosterone. Lancet 1994, 343: 1479-1481.
7. Haffner S.M., Valdez R.A. Endogenous sex hormones: impact on lipids, lipoproteins, and insulin. Am. J. Med. 1995, 98: 40S-47S.
8. Herbert J. The age of dehydroepiandrosterone. Lancet 1995, 345: 1193-1194.
9. Khaw K.T. Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease. J. Endocrinol. 1996, 150: (suppl S 149-S 153).
10. Wolf O.T., Kirschbaum C. Wishing a dream came true: DHEA as a rejuvenating treatment? J. Endocrinol. Invest. 1998, 21: 133-135.
11. Labrie F. DHEA as physiological replacement therapy at menopause. J. Endocrinol. Invest. 1998, 27: 399-401.
12. Donahue R.P., Abbott R.D., Bloom E., Read D.M., Yano K. Central obesity and coronary heart disease in men Lancet 1987, 1: 821-824.
13. Nestler J.E., Clore J.N., Strauss III J.F., Blackard W.G. The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. J. Clin. Endocrinol. Metab. 1987, 64: 180-184.
14. Schriock E.D., Buffington C.K., Hubert G.D., Kurtz B.R., Kitabchi A.E., Buster J.E., Givens J.R. Divergent correlation of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding. J. Clin. Endocrinol. Metab. 1988, 66: 1329-1331.
15. Diamond M.P., Grainger D.A., Laudano A.J., Starick-Zych K., De Fronzo R.A. Effect of acute physiological elevate of insulin on circulating androgen levels in nonobese women. J. Clin. Endocrinol. Metab. 1991, 72: 883-887.
16. Nestler J.E., McClanahan A., Clore J.N., Blackard W.G. Insulin inhibits adrenal 17, 20-lyase activity in man. J. Clin. Endocrinol. Metab. 1992, 74: 362-367.
17. Ebeling P., Stenman U.H., Seppala M., Koivisto V.A. Acute hyperinsulinemia, androgen homeostasis and insulin sensitivity in healthy man. J. Endocrinol. 1995, 746: 63-69.
18. Herrington D.H., Gordon G.B., Achuff S.C., Trejo J.F., Weisman H.F., Kwiterovich P.O., Pearson T.A. Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography. J. Am. Coll. Cardiol. 1990, 76: 862-870.
19. Feldman H.A., Johannes C.B., McKinlay J.B., Longcope C. Low dehydroepiandrosterone sulfate and heart disease in middle-aged men: cross-sectional results from the Massachusetts Male Aging Study. Ann. Epidemiol. 1998, 8: 217-228.
20. Jakubowicz D.J., Beer N.A., Beer R.M., Nestler J.E. Disparate effects of weight reduction by diet on serum dehydroepiandrosterone-sulfate levels in obese men and women. J. Clin. Endocrinol. Metab. 1995, 80: 3373-3376.
21. Azziz R., Zacur H.A., Parker Jr. C.R., Bradley Jr. E.L., Boots L.R. Effect of obesity on the response to acute adrenocorticotropin stimulation in eumenorrheic women. Fertil. Steril. 1991, 56: 427-433.
22. Holte J., Bergh T., Gennarelli G., Wide L. The independent effects ot polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Clin. Endocrinol. (Oxf.) 1994, 47: 473-481.
23. Weiss D.J., Charles M.A., Dunaif A., Prior D.E., Lillioja S., Knowler W.C., Herman W.H. Hyperinsulinemia is associated with menstrual irregularity and altered serum androgens in Pima Indian women. Metabolism 1994, 43: 803-807.
24. Tchernof A., Despres J.P., Belanger A., Dupont A., Prud'homme D., Moorjani S., Lupien P.J., Labrie F. Reduced testosterone and adrenal C19 steroid levels in obese men. Metabolism 1995, 44: 513-519.
25. Barrett-Connor E., Ferrara A. Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and non insulin-dependent diabetes in postmenopausal women: the Rancho Bernardo Study. J. Clin. Endocrinol. Metab. 1996, 81: 59-64.
26. th ed., W.B. Saunders Company, Philadelphia, 1998, p. 1061-1097.
27. rd edition. Mc Graw Hill, New York, 1995, p. 1271-1298.
28. Leenen R., Van der Kooy K., Seidell J.C., Deurenberg P., Koppeschaar H.P.F. Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy. J. Clin. Endocrinol. Metab. 1994, 78: 1515-1520.
29. Crave J.C., Fimbel S., Lejeune H., Cugnardey N., Dechaud H., Pugeat M. Effects of diet and metformin administration on sex-hormone binding globulin, androgens and insulin in hirsute and obese women. J. Clin. Endocrinol. Metab. 1995, 80: 2057-2062.
30. Rasmussen M.H., Hvidberg A., Juul A., Main K.M., Gotfredsen A., Skakkebae N.E., Hilsted J. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J. Clin. Endocrinol. Metab. 1995, 80: 1407-1514.
31. Procopio M., Maccario M., Grottoli S., Oleandri S.E., Boffano G.M., Camanni F., Ghigo E. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine. Clin. Endocrinol. (Oxf.) 1995, 43: 665-669.
32. Beer N.A., Jakubowicz D.J., Beer P.M., Nestler J.E. Disparate effects of insulin reduction with di diltiazem on serum dehydroepiandrosterone-sulfate levels in obese hypertensive men and women. J. Clin. Endocrinol. Metab. 1994, 79: 1077-1081.
33. Nestler J.E., Barlascini C.O., Clore J.N., Blackard W.G. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J. Clin. Endocrinol. Metab. 1988, 66: 57-61.
34. Haffner S.M., Valdez R.A., Mykkanen L., Stern M.P., Katz M.S. Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in non-diabetic men. Metabolism 1994, 43: 599-603.
35. Liu C.H., Laughlin G.A., Fischer U.G., Yen S.S.C. Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in post-menopausal women: evidence for a reduced 17,20 desmolase enzymatic activity. J. Clin. Endocrinol. Metab. 1990, 71: 900-906.
36. Parker C.R. Jr., Mixon R.L, Brissie R.M., Grizzle W.E. Aging alters zonation of the adrenal cortex of men. J. Clin. Endocrinol. Metab. 1997, 82: 3898-3901.
37. Jung R. Endocrinological aspects of obesity. Clin. Endocrinol. Metab. 1984, 13: 597-612.
38. Pasquali R., Cantobelli S., Casimirri F. Capelli M., Bortoluzzi R., Flamia R., Labate A.M.M., Barbara L. The hypothalamo-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J. Clin. Endocrinol. Metab. 1993, 77: 341-346.
39. Parker L.N., Levin E.R., Lifrak E.T. Evidence for adrenocortical adaptation to severe illness J. Clin. Endocrinol. Metab. 1985, 60: 947-952.
40. Devesa J., Perez Fernandez R., Bokser L., Gaudiero G.J., Luna L., Casanueva F.F. Adrenal androgen secretion and dopaminergic activity in anorexia nervosa. Horm. Metab. Res. 1988, 20: 57-60.